Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection-Reference-Cited by-同舟云学术

Safety and efficacy of glecaprevir and pibrentasvir in north Tohoku Japanese patients with genotype 1/2 hepatitis C virus infection

Published:2022-01 Issue:1 Volume:5 Page:
ISSN:2398-8835
Container-title:Health Science Reports
language:en
Short-container-title:Health Science Reports

Author:

Miyasaka Akio¹^ORCID,Yoshida Yuichi¹^ORCID,Murakami Akihiko²^ORCID,Hoshino Takao³^ORCID,Sawara Kei¹⁴^ORCID,Numao Hiroshi⁵^ORCID,Takikawa Yasuhiro¹⁶^ORCID

Affiliation:

1. Division of Hepatology, Department of Internal Medicine Iwate Medical University School of Medicine Shiwa‐gun Japan

2. Department of Gastroenterology Iwate Prefectural Miyako hospital Miyako Japan

3. Department of Gastroenterology Akita Kosei Medical Center Akita Japan

4. Department of Gastroenterology Iwate Prefectural Kamaishi Hospital Kamaishi Japan

5. Department of Gastroenterology Aomori Prefectural Central Hospital Aomori Japan

6. Department of Hepatology San‐ai hospital Morioka Japan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hsr2.458

Reference28 articles.

1. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus

2. Natural history of liver fibrosis progression in patients with chronic hepatitis C

3. Treatment of hepatitis C virus infection with direct-acting antiviral agents: 100% cure?

4. Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis

5. Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 2 hepatitis C virus infection

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experience with direct-acting antivirals in genotype 1–5 infected chronic hepatitis C patients in Turkey;Annals of Saudi Medicine;2023-09

2. Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center;Cureus;2023-07-12

3. Risk Factors of Glecaprevir/Pibrentasvir-Induced Liver Injury and Efficacy of Ursodeoxycholic Acid;Viruses;2023-02-09

4. A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD;Kidney International Reports;2023-02

5. Virus-Associated Nephropathies: A Narrative Review;International Journal of Molecular Sciences;2022-10-10